Jennifer Klemp, Ph.D., M.P.H., asks the questions that remain unanswered in breast cancer survivorship.
Jennifer Klemp, Ph.D., M.P.H., asks the questions that remain unanswered in breast cancer survivorship.
First, she asks if every patient should get a survivorship plan. Klemp says they should, especially as there are now women with metastatic disease who are living for many years.
Next, she notes that survivorship education and symptom mitigation should be moved up to the time of diagnosis, not after treatment.
Finally, Klemp asks a pressing question on the minds of many patients and providers: how are we going to pay for all of this?
FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment
February 5th 2024One cancer vaccine may still be years away from being available, a breast cancer test may be misguiding treatments for Black women and the review of two oncology regimens are being expedited by the FDA.
Listen